x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:07:47

State of Possible: On the one-year anniversary of the...

BiotechTV - News ·

2025/03/26

She describes the idea of leveraging Glyph to achieve oral dosing of medicines in cases where it would not be possible or tolerable. Plus, the lead clinical program, allopregnanolone, how the company thinks about avoiding high placebo responses in trials, and other programs.

en-us

00:12:51

State of Possible: Beam Therapeutics' CEO John Evans...

BiotechTV - News ·

2025/03/26

He describes the nine patient dose ascending data in AAT deficiency that was historic for being the industry's first in-vivo proof of concept of a gene editor. Plus, what's next for that program and sickle cell, and the decision to do an "over the wall" financing.

en-us

00:13:16

State of Possible: Cigall Kadoch discusses her...

BiotechTV - News ·

2025/03/26

She describes the science behind chromatin and gene regulation, previews upcoming preclinical data the company will have at AACR for its lead SMARCA2 program (partnered with Lilly), and discusses what she would like to see out of future phase 1 data.

en-us

00:11:50

State of Possible: Kymera Therapeutics Founder and...

BiotechTV - News ·

2025/03/26

He gives a brief overview of this approach, comments on recent competitor data in cancer, and highlights Kymera's STAT6 and TYK2 programs.

en-us

00:06:11

State of Possible: Massachusetts Governor Maura...

BiotechTV - News ·

2025/03/26

She describes the efforts that government is making to support medical research in the area, shares her thoughts on competition in science and for jobs from China, and her thoughts on how the industry can improve its messaging.

en-us

00:13:25

State of Possible: Strand Therapeutics' Co-Founder &...

BiotechTV - News ·

2025/03/26

He describes the intratumoral IL-12 program that is in the clinic today, and the preclinical progress Strand is making on its other programs. Plus, his thoughts on the current public perception of mRNA.

en-us

00:21:50

At an R&D event hosted by the company in Kendall...

BiotechTV - News ·

2025/03/25

He described the discovery work that Alloy does with its client partners, and highlighted emerging areas of science. Plus, the importance of good murine models, and his take on Chinese competition.

en-us

00:13:48

Oxford, UK based Greywolf Therapeutics is pursuing...

BiotechTV - News ·

2025/03/25

Co-Founder and CEO Peter Joyce describes the science behind this, including how the company's lead programs inhibit Endoplasmic Reticulum Associated Proteases (ERAPs). A clinical stage company, he describes Greywolf's clinical experience and fundraising history.

en-us

00:12:42

Brainomix, an Oxford, UK based company that uses AI...

BiotechTV - News ·

2025/03/20

Co-Founder and CEO Michalis Papadakis describes the unmet need for a quick, accurate assessment of stroke damage by front line physicians, who otherwise might not be experts in the area. Plus, moving the technology to lung disease and beyond.

en-us

00:09:50

AnaptysBio's CEO discusses recent 12 week RA data...

BiotechTV - News ·

2025/03/19

Daniel Faga goes over the recently released rosnilimab RA data and previews a longer-term follow-up that will be out in the second quarter. Plus, ulcerative colitis data that will be out in the fourth quarter and the opportunity there. He also highlights the company's PD-1 for oncology that is commercialized by GSK.

en-us

00:23:47

Analyst Tuesdays: Mizuho Senior Analyst Graig...

BiotechTV - News ·

2025/03/18

He sets the table for upcoming readouts from Axsome, Vigil Neuro, Verastem, Corvus, and Harmony Biosciences.

en-us

00:17:14

The co-founders of Vevo Therapeutics describe the Arc...

BiotechTV - News ·

2025/03/17

CEO Nima Alidoust and CSO Johnny Yu describe Vevo's contribution of 100M cells, plus a 60,000 drug-patient interaction map, that has been combined with Arc's 200M cell gene expression data from 21 different species (scBaseCamp). They explain the size and scale of this now open source atlas, and the potential utility of it to outside researchers.

en-us

00:11:07

From struggling with sickle cell disease to climbing...

BiotechTV - News ·

2025/03/14

Jimi Olaghere describes how his life has changed after participating in a clinical trial for the CRISPR based gene therapy for sickle cell disease that is now called CASGEVY. He describes what it was like receiving the treatment, and discusses the need for more awareness and access in the sickle cell community worldwide for this type of treatment.

en-us

00:18:30

Bonum Therapeutics aims to lower the toxicity of...

BiotechTV - News ·

2025/03/14

Founder & CEO John Mulligan describes how he and his team sold an asset using the same science to Roche in 2022 for $250 million when they were Good Therapeutics, and how the follow-on company Bonum aims to test this approach more broadly. He describes how it works, and discusses the initial programs they have chosen, with a LAG3-IL2 being the most advanced.

en-us

00:06:16

Alta Partners' Managing Director Bob More shares his...

BiotechTV - News ·

2025/03/14

He discusses the current downturn, they key of being focused, and his preference of investing in people first. Plus, comments on portfolio companies eGenesis and Vir Biotechnology.

en-us

00:05:38

Congratulations to Luke Timmerman on 10 years of...

BiotechTV - News ·

2025/03/14

Celebrating with the Seattle (and beyond) biotech community.

en-us

00:07:04

Tour of Scotland: Glasgow based EnteroBiotix is...

BiotechTV - News ·

2025/03/13

CEO Jame Mcllroy describes the scientific platform and how it contrasts to other microbiome approaches. A trial in IBS is scheduled to read out immanently.

en-us

00:05:46

Tour of Scotland: Scotland's Chief Scientist (Health)...

BiotechTV - News ·

2025/03/13

Professor Dame Anna Dominiczak describes how new technologies are being rolled out in the community equitably, such as digital dermatology, and invites companies to run clinical trials in Scotland.

en-us

00:16:48

HumanX: Generate Biomedicines' CEO Mike Nally...

BiotechTV - News ·

2025/03/13

From the big HumanX AI conference in Las Vegas, he describes the overall path he sees AI taking in its contributions to drug development, and gives an update on Generate's programs regarding TSLP, IL13, ADCs, and more.

en-us

00:05:51

Tour of Scotland: St. Andrews based Pneumagen aims to...

BiotechTV - News ·

2025/03/13

Co-Founder & CEO Douglas Thomson describes how the company was founded, and walks us through the science. Plus, a recap of recently presented phase 2 data, and the road ahead.

en-us

432 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter